Elevance Health (NYSE:ELV) – What to Know About B of A Securities’ Elevance Health Upgrade

B of A Securities upgraded Elevance Health rating ELV buy with a price target of $575.00, changing its price target from $535.00 to $575.00.

Shares of Elevance Health are trading up 1.5% in the past 24 hours, at $496.71 per share.

A move to $575.00 would represent a 15.76% increase over the current stock price.

About Elevance Health

Elevance Health (formerly known as Anthem) remains one of the largest health insurers in the United States, providing medical benefits to approximately 45 million medical members. The company offers employer, individual and government coverage plans. Elevance sets itself apart from its peers through its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as a licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance’s reach also extends beyond these states through government-sponsored programs such as Medicaid.

About analyst ratings

Analysts work in banking and financial systems and typically specialize in reporting on stocks or defined sectors. Analysts can attend company conference calls and meetings, research company financials, and communicate with insiders to issue “analyst notes” for stocks. Analysts typically rate each stock once a quarter.

Some analysts will also offer forecasts for metrics such as growth estimates, earnings, and revenue to provide additional stock insights. Investors using analyst ratings should note that such expert advice is human-sourced and may be subject to error.

If you want to track which analysts are outperforming others, you can view updated analyst ratings as well as analyst pass scores in Benzinga Pro.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Previous Bringing AI to inventory optimization
Next Top 5 Loan Companies No Credit Check and Guaranteed Approval